| 163.95 1.22 (0.75%) | 07-31 10:47 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 196.75 | 1-year : | 203.33 |
| Resists | First : | 168.45 | Second : | 174.08 |
| Pivot price | 163 |
|||
| Supports | First : | 159.33 | Second : | 132.57 |
| MAs | MA(5) : | 164.08 |
MA(20) : | 163.59  |
| MA(100) : | 165.84 |
MA(250) : | 161.7 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 38.5 |
D(3) : | 46.3 |
| RSI | RSI(14): 48.6 |
|||
| 52-week | High : | 183.89 | Low : | 138.31 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BCpC ] has closed below upper band by 43.5%. Bollinger Bands are 52% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 164.33 - 165.23 | 165.23 - 165.97 |
| Low: | 158.7 - 159.82 | 159.82 - 160.76 |
| Close: | 161.02 - 162.75 | 162.75 - 164.19 |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Fri, 31 Jul 2026
Balchem Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Fri, 31 Jul 2026
Is Balchem Corp (BCPC) Undervalued After Q2 Earnings Beat? GF Sc - GuruFocus
Fri, 31 Jul 2026
Balchem earnings beat by $0.24, revenue topped estimates - Investing.com
Fri, 31 Jul 2026
Balchem Reports Q2 2026: Revenue $284.0M, Net Earnings $44.6M, Adjusted EPS $1.49 - TradingView
Fri, 31 Jul 2026
BALCHEM ($BCPC) Releases Q2 2026 Earnings - Quiver Quantitative
Fri, 31 Jul 2026
Balchem Corporation Reports Second Quarter 2026 Financial Results - The Manila Times
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 32 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 92 (%) |
| Shares Short | 605 (K) |
| Shares Short P.Month | 419 (K) |
| EPS | 4.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 40 |
| Profit Margin | 14.9 % |
| Operating Margin | 20.8 % |
| Return on Assets (ttm) | 8 % |
| Return on Equity (ttm) | 12.6 % |
| Qtrly Rev. Growth | 8.1 % |
| Gross Profit (p.s.) | 11.93 |
| Sales Per Share | 32.99 |
| EBITDA (p.s.) | 8.13 |
| Qtrly Earnings Growth | 10.6 % |
| Operating Cash Flow | 220 (M) |
| Levered Free Cash Flow | 138 (M) |
| PE Ratio | 33.55 |
| PEG Ratio | 3.7 |
| Price to Book value | 4.08 |
| Price to Sales | 4.95 |
| Price to Cash Flow | 23.84 |
| Dividend | 0.95 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|